OPPI urges government to boost R&D and innovation in pharma sector ahead of Union Budget
Anil Matai, Director General of OPPI, highlights key recommendations for enhancing pharmaceutical development in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Union Budget
Budget expectation: Focus on encouraging R&D in pharma sector
Sanjay Vyas, Executive Vice President and Managing Director, Parexel India shares his budget expectations
Budget expectation: Bring GST rate on APIs at par with the formulations
Joydeep Ghosh Partner, Industry Leader-Life Science & Healthcare, Deloitte shares his budget expectations for lifesciences